Conexeu Sciences Inc.
StreetZero Signal 68
About Conexeu Sciences Inc.
Conexeu Sciences Inc. is a biotechnology company advancing regenerative medicine with its patented collagen flowable gel platform. Emerging from over a decade of University research, the company is developing this technology for applications in wound care, veterinary medicine, 3D bioprinting and other verticals. It is headquartered in Reno, Nevada and trades under the ticker CNXU.
LATEST FUNDINGPrivate Placement
$252K
Announced 2026-09-15
TOTAL RAISED$5M
IN THE NEWS
- 🔗 Conexeu Sciences Closes Maximum $5M Reg CF Financing
- 🔗 Conexeu Sciences Closes Maximum $5M Reg CF Financing | Conexeu
- 🔗 Conexeu Sciences Inc. (CNXU) – A Biotech Stock Worth Watching | Conexeu
- 🔗 Conexeu Sciences Inc.: Form S-1/A - Filed by newsfilecorp.com
- 🔗 Architecting Bioregeneration | Conexeu Sciences (CNXU)
EMPLOYEES—
FOUNDED—
HQReno, NV, USA
Industry
Biotechnology
Tags
BiotechnologyRegenerative MedicineCollagen PlatformReg CF
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Closed maximum $5M Reg CF financing in October 2025 via Equifund platform
- Patented collagen flowable gel platform targets wound care, veterinary and 3D bioprinting markets
- Company holds global rights to core collagen/ECM IP with no licensing or royalty obligations
- As of October 2025 held approximately $4.8M in cash following the raise
- Plans to ring the Nasdaq Closing Bell in June 2026
Ask StreetZero about Conexeu Sciences Inc.
Put our AI to work on this deal.
Similar companies
Other Biotechnology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account